Clinical studies

For each clinical trial conducted at the University Hospital Erlangen and at the sites of the cooperation partners of the CCC Erlangen-EMN (Hospital Bayreuth GmbH, Bamberg Social Foundation, St. Marien Amberg Hospital, Fürth Hospital, Nuremberg Hospital, Sana Hospital Hof), you will find key data such as study title, brief descriptions, basic inclusion and exclusion criteria, study status and the study contact person in our study database  

To search for studies, you can enter your search term directly in the search field. The filter function in the left column allows you to further narrow down your search. This allows you to search specifically for studies at a certain location or for a certain disease.

The Interdisciplinary Clinical Trial Unit (ICTU) is a joint structure of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg, the University Hospital Erlangen and the Comprehensive Cancer Center Erlangen-EMN, as well as the German Center for Immunotherapy (DZI). At the same time, the ICTU is part of the Bavarian Center for Cancer Research (BZKF), as well as NCT WERA, with close cooperation throughout Bavaria with other university locations in Munich, Augsburg, Regensburg and Würzburg. Within the framework of the CCC Erlangen-EMN, the ICTU/ECTU is also networked with the hospital sites in Amberg, Bamberg, Bayreuth, Fürth, Hof and Nuremberg, so that there is also close cooperation within Franconia.

The ICTU is a central, interdisciplinary clinical study unit for the conduct of clinical trials. It also houses the Early Clinical Trial Unit (ECTU), a highly specialized, interdisciplinary clinical unit for conducting experimental tumor therapies as part of phase I/II studies at the hospital. Beyond its oncology focus, the ECTU also supports the conduct of innovative early clinical trials in other research areas.